Literature DB >> 21125332

Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women.

Fan-Yun Mong1, Yu-Liang Kuo, Ching-Wen Liu, Wen-Sheng Liu, Li-Ching Chang.   

Abstract

Given the essential role of prolactin (PRL) and its receptor (PRLR) in breast tumorigenesis, we investigated whether single nucleotide polymorphisms (SNPs) in the PRL and PRLR genes were associated with breast cancer in Taiwanese women. A total of 160 breast cancer patients and 336 unrelated control Taiwanese women were enrolled in this study. Three SNPs (rs1341238, rs2244502 and rs3756824) in the PRL gene and one SNP (rs10941235) in the PRLR gene were genotyped using allele-specific polymerase chain reaction and DNA sequencing. We showed that the PRLR SNP rs10941235 was associated with breast cancer (P < 0.05) and its genotype frequencies in the breast cancer group were significantly associated (P < 0.05) with the levels of cancer antigen 15-3, a serum biomarker of breast cancer. The PRL SNP rs3756824 was significantly associated with breast cancer metastasis (P < 0.05). These findings suggest that the polymorphism rs10941235 in the PRLR gene is associated with breast cancer and cancer antigen 15-3 levels in Taiwanese women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125332     DOI: 10.1007/s11033-010-0596-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Cellular expression of growth hormone and prolactin receptors in human breast disorders.

Authors:  H C Mertani; T Garcia-Caballero; A Lambert; F Gérard; C Palayer; J M Boutin; B K Vonderhaar; M J Waters; P E Lobie; G Morel
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

2.  Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.

Authors:  P Touraine; J F Martini; B Zafrani; J C Durand; F Labaille; C Malet; A Nicolas; C Trivin; M C Postel-Vinay; F Kuttenn; P A Kelly
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.

Authors:  S E Hankinson; W C Willett; D S Michaud; J E Manson; G A Colditz; C Longcope; B Rosner; F E Speizer
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

Review 4.  Mechanisms of prolactin receptor regulation in mammary gland.

Authors:  C J Ormandy; R L Sutherland
Journal:  Mol Cell Endocrinol       Date:  1993-02       Impact factor: 4.102

5.  Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

Authors:  S K Peirce; W Y Chen; W Y Chen
Journal:  J Endocrinol       Date:  2001-10       Impact factor: 4.286

Review 6.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.

Authors:  J M Bhatavdekar; D D Patel; N G Shah; H H Vora; T P Suthar; N Ghosh; P R Chikhlikar; T I Trivedi
Journal:  Eur J Surg Oncol       Date:  2000-09       Impact factor: 4.424

Review 8.  Prolactin involvement in breast cancer.

Authors:  B K Vonderhaar
Journal:  Endocr Relat Cancer       Date:  1999-09       Impact factor: 5.678

Review 9.  Prolactin as an autocrine/paracrine growth factor in human cancer.

Authors:  Nira Ben-Jonathan; Karen Liby; Molly McFarland; Michael Zinger
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

10.  Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).

Authors:  Jonas Manjer; Robert Johansson; Göran Berglund; Lars Janzon; Rudolf Kaaks; Asa Agren; Per Lenner
Journal:  Cancer Causes Control       Date:  2003-09       Impact factor: 2.506

View more
  5 in total

1.  Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.

Authors:  Kathleen A O'Leary; Michael P Shea; Linda A Schuler
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.

Authors:  Obi L Griffith; Szeman Ruby Chan; Malachi Griffith; Kilannin Krysiak; Zachary L Skidmore; Jasreet Hundal; Julie A Allen; Cora D Arthur; Daniele Runci; Mattia Bugatti; Alexander P Miceli; Heather Schmidt; Lee Trani; Krishna-Latha Kanchi; Christopher A Miller; David E Larson; Robert S Fulton; William Vermi; Richard K Wilson; Robert D Schreiber; Elaine R Mardis
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

Review 3.  The prolactin receptor: Diverse and emerging roles in pathophysiology.

Authors:  Caroline M Gorvin
Journal:  J Clin Transl Endocrinol       Date:  2015-05-16

Review 4.  Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.

Authors:  Raghuveer Kavarthapu; Maria L Dufau
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

5.  The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome.

Authors:  Doonyapat Sa-Nguanraksa; Cholladda Thasripoo; Norasate Samarnthai; Tanawan Kummalue; Thanawat Thumrongtaradol; Pornchai O-Charoenrat
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.